Want to see IN:VIJAYA full AI Analyst Report?
VIJAYA Stock Chart & Stats
₹1055.40
-₹0.50(-0.04%)
At close: 4:00 PM EST
₹1055.40
-₹0.50(-0.04%)
Day’s Range― - ―
52-Week Range₹847.90 - ₹1,425.00
Previous CloseN/A
Volume710.73K
Average Volume (3M)7.14K
Market Cap
₹140.43B
Enterprise Value₹137.32B
Total Cash (Recent Filing)₹2.58B
Total Debt (Recent Filing)₹3.65B
Price to Earnings (P/E)83.1
Beta0.71
Next Earnings
Aug 11, 2026EPS Estimate
4.36Next Dividend Ex-DateN/A
Dividend Yield0.2%
Share Statistics
EPS (TTM)14.77
Shares Outstanding102,896,730
10 Day Avg. Volume16,300
30 Day Avg. Volume7,139
Financial Highlights & Ratios
PEG Ratio2.57
Price to Book (P/B)9.51
Price to Sales (P/S)11.18
P/FCF Ratio103.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)21.59
Revenue Forecast (FY)₹9.68B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained top-line growth with acceleration into 2026 indicates expanding demand and successful market penetration. For a diagnostics firm, consistent revenue gains support fixed-cost absorption, justify capital reinvestment in labs/imaging, and underpin multi-quarter earnings resilience.
High And Stable ProfitabilityDurable margins reflect pricing power, efficient lab operations and scale benefits from a hub-and-spoke model. High EBITDA margins provide cover for reinvestment and debt servicing, supporting long-term cash generation and making earnings less sensitive to modest volume fluctuations.
Strong Operating Cash GenerationOperating cash consistently exceeding accounting profit signals high earnings quality and strong conversion before capex. Reliable cash flow coverage supports network expansion, equipment replacement and flexible capital allocation without immediate reliance on external financing.
Bears Say
Uneven Free Cash Flow ConversionVolatile FCF conversion points to swings from capex timing or working-capital cycles that can strain liquidity in weaker revenue periods. This variability reduces predictability of internal funding for expansion and may force episodic external financing or slower organic rollouts.
Rising Absolute DebtAn uptick in absolute leverage, even from moderate levels, raises interest and refinancing exposure if growth or margins decelerate. For capital-intensive diagnostics (imaging equipment), higher debt can limit flexibility for opportunistic investments or increase vulnerability to policy or rate shifts.
Historic Gross Margin VolatilityA sharp prior gross-margin decline suggests exposure to input-cost swings, pricing pressure or mix shifts. Persistent or recurring cost volatility could compress long-term profitability and weaken the structural margin advantage that funds capital spending and network expansion.
Vijaya Diagnostic Centre Ltd. News
VIJAYA FAQ
What was Vijaya Diagnostic Centre Ltd.’s price range in the past 12 months?
Vijaya Diagnostic Centre Ltd. lowest stock price was ₹847.90 and its highest was ₹1425.00 in the past 12 months.
What is Vijaya Diagnostic Centre Ltd.’s market cap?
Vijaya Diagnostic Centre Ltd.’s market cap is ₹140.43B.
When is Vijaya Diagnostic Centre Ltd.’s upcoming earnings report date?
Vijaya Diagnostic Centre Ltd.’s upcoming earnings report date is Aug 11, 2026 which is in 37 days.
How were Vijaya Diagnostic Centre Ltd.’s earnings last quarter?
Vijaya Diagnostic Centre Ltd. released its earnings results on May 07, 2026. The company reported ₹4.7 earnings per share for the quarter, beating the consensus estimate of ₹4.213 by ₹0.487.
Is Vijaya Diagnostic Centre Ltd. overvalued?
According to Wall Street analysts Vijaya Diagnostic Centre Ltd.’s price is currently Overvalued.
Does Vijaya Diagnostic Centre Ltd. pay dividends?
Vijaya Diagnostic Centre Ltd. pays a Annually dividend of ₹2 which represents an annual dividend yield of 0.2%. See more information on Vijaya Diagnostic Centre Ltd. dividends here
What is Vijaya Diagnostic Centre Ltd.’s EPS estimate?
Vijaya Diagnostic Centre Ltd.’s EPS estimate is 4.36.
How many shares outstanding does Vijaya Diagnostic Centre Ltd. have?
Vijaya Diagnostic Centre Ltd. has 102,896,730 shares outstanding.
What happened to Vijaya Diagnostic Centre Ltd.’s price movement after its last earnings report?
Vijaya Diagnostic Centre Ltd. reported an EPS of ₹4.7 in its last earnings report, beating expectations of ₹4.213. Following the earnings report the stock price went up 1.644%.
Which hedge fund is a major shareholder of Vijaya Diagnostic Centre Ltd.?
Currently, no hedge funds are holding shares in IN:VIJAYA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Limited delivers a broad spectrum of diagnostic services to patients across India. Its extensive laboratory offerings include clinical biochemistry, haematology (and immune-haematology), clinical pathology, histopathology, cytopathology, microbiology, serology, cytogenetics, and molecular pathology. For imaging, the company provides advanced radiology services such as magnetic resonance imaging (MRI), multi-slice CT, 3D dental CBCT, mammography, DEXA/bone densitometry, ultrasound with color doppler, nuclear medicine including PET/CT, and digital X-rays. Beyond these, specialized services cover cardiology, neurology, and gastroenterology. The center also offers health check-up packages and convenient home sample collection. Headquartered in Hyderabad, India, and founded in 1981, Vijaya Diagnostic Centre operates a significant network of 80 diagnostic centers and 11 reference laboratories. These facilities are spread across 13 cities and towns, primarily in Telangana and Andhra Pradesh, alongside the National Capital Region and Kolkata.
Technical Analysis
Krsnaa Diagnostics Limited
―
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Suraksha Diagnostic Ltd.
―
Thyrocare Technologies Ltd
―